Spectral Med Stock Today
| EDTXF Stock | USD 0.35 0.03 7.89% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Spectral Med is trading at 0.35 as of the 18th of January 2025. This is a 7.89 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.35. Spectral Med has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. The company has 278.22 M outstanding shares. More on Spectral Med
Moving together with Spectral Pink Sheet
| 0.77 | PKX | POSCO Holdings Earnings Call This Week | PairCorr |
Moving against Spectral Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Spectral Pink Sheet Highlights
| Business Concentration | Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) |
Spectral Med [EDTXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Micro-Cap' category with a current market capitalization of 66.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spectral Med's market, we take the total number of its shares issued and multiply it by Spectral Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Spectral Med classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 278.22 M outstanding shares.
Spectral Med has accumulated about 3.47 M in cash with (8.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Spectral Med Probability Of Bankruptcy
Ownership AllocationSpectral Med shows a total of 278.22 Million outstanding shares. Spectral Med maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Spectral Ownership Details
Spectral Med Risk Profiles
| Mean Deviation | 2.71 | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.4 | |||
| Risk Adjusted Performance | (0.02) |
Spectral Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Spectral Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Spectral Med Corporate Management
| Sam Amory | Pres Inc | Profile | |
| BSc RN | VP Devel | Profile | |
| Blair McInnis | Chief Officer | Profile | |
| Christopher Seto | CEO Director | Profile | |
| John MD | Chief Officer | Profile |
Other Information on Investing in Spectral Pink Sheet
Spectral Med financial ratios help investors to determine whether Spectral Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.